invasight.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://www.invasight.com/sitemap_index.xml # --------------------------- # END YOAST | ||
Meta Tags
| Title | Home - |
| Description | Advanced targeted therapies for invasive Home News Contact info@invasight.com Advanced targeted therapies for invasive cancers About Breakthrough technology enabling first in class therapies We d |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 52.21.96.107 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
invasight.com Valuation
|
US$1,470
Last updated: 2023-05-15 16:35:21
invasight.com has Semrush global rank of 0. invasight.com has an estimated worth of US$ 1,470, based on its estimated Ads revenue. invasight.com receives approximately 169 unique visitors each day. Its web server is located in United States, with IP address 52.21.96.107. According to SiteAdvisor, invasight.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,470 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$40 |
| Yearly Ads Revenue | US$488 |
| Daily Unique Visitors | 11 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| invasight.com. | A | 3599 | IP: 52.21.96.107 |
| invasight.com. | A | 3599 | IP: 52.4.76.39 |
| invasight.com. | A | 3599 | IP: 52.7.59.11 |
| invasight.com. | A | 3599 | IP: 52.3.106.31 |
| invasight.com. | NS | 3600 | NS Record: ns11.domaincontrol.com. |
| invasight.com. | NS | 3600 | NS Record: ns12.domaincontrol.com. |
| invasight.com. | MX | 3600 | MX Record: 0 invasight-com.mail.protection.outlook.com. |
| invasight.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-15 16:35:21
| Home News Contact info@invasight.com Advanced targeted therapies for invasive cancers About Breakthrough technology enabling first in class therapies We develop first-in-class protein-protein interaction antagonists (PPIAs) against invasive cancers. Our breakthrough technology, ACINDA, accelerates drug discovery and enables the precise design of small molecule inhibitors against specific proteins which cause cancer cell invasion . Our first-in-class protein-protein integration antagonists (PPIAs) combine potent anti-tumour activity with a favourable safety profile for patients with invasive cancers. PRODUCT F2i: Invasight’s first drug development program Invasight’s first drug development program targets pro-invasive fibroblast growth factor (FGF) signalling in human cancers. Leveraging ACINDA, we have developed ’F2i’, a first-in-class, non-kinase, small molecule PPIA of the FGF signalling pathway. Traditionally, FGF signalling pathways are targeted via direct or indirect small |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Wed, 05 Jan 2022 08:54:05 GMT Connection: keep-alive Location: https://invasight.com/ X-Content-Type-Options: nosniff X-Frame-Options: SAMEORIGIN X-XSS-Protection: 1 ; mode=block Referrer-Policy: no-referrer-when-downgrade Server: haproxy HTTP/2 200 content-type: text/html content-length: 77074 date: Wed, 05 Jan 2022 08:54:06 GMT accept-ranges: bytes x-amz-meta-pc-last-modified: 1623224752.9578037 last-modified: Wed, 09 Jun 2021 07:45:53 GMT server: haproxy etag: "1947c5697ebf99f986eaeaad30c945e8" x-frame-options: SAMEORIGIN strict-transport-security: max-age=31557600; includeSubDomains |
invasight.com Whois Information
Domain Name: INVASIGHT.COM Registry Domain ID: 2325239290_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-11-02T16:43:00Z Creation Date: 2018-10-24T10:39:12Z Registry Expiry Date: 2022-10-24T10:39:12Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS11.DOMAINCONTROL.COM Name Server: NS12.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-01-06T07:02:11Z <<< |